Filter Initial & Long Term Evaluation After Placement and Retrieval Registry
Launched by STANFORD UNIVERSITY · Jul 7, 2010
Trial Information
Current as of November 08, 2025
Recruiting
Keywords
ClinConnect Summary
The Filter Initial & Long Term Evaluation After Placement and Retrieval Registry is a clinical trial aimed at studying how well the IVC (Inferior Vena Cava) filter works for patients with a condition called venous thromboembolism, which involves blood clots in the veins. This study will look at patients who are already scheduled to have an IVC filter placed or removed at Stanford. If you are an adult aged 18 or older and undergoing this procedure, you might be eligible to participate in the trial.
As a participant, you will be asked if you want to join the study before your procedure. If you agree, the researchers will collect information about your health and how well you respond to the treatment over time. There are no specific exclusions for this trial, which means almost anyone who meets the age and procedure criteria can participate. This study will help improve our understanding of IVC filters and how they affect patients in both the short and long term.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants are adults, 18 years old or older
- • Participants will be undergoing a procedure to have an IVC filter placed or removed
- Exclusion Criteria:
- • None
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Trial Officials
William T Kuo MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials